Article

Cell-free DNA Whole Genome Sequencing for Non-Invasive Minimal Residual Disease Detection in Multiple Myeloma

2025-10-27

Abstract excerpt

Minimal residual disease (MRD) monitoring in multiple myeloma (MM) relies on invasive bone marrow (BM) biopsies, which often yield insufficient tumor material. We performed whole genome sequencing of cell-free DNA from 163 plasma samples from 51 patients to develop a non-invasive MRD classifier. BM WGS identified a median of 2,502 clonal mutations, enabling cfDNA tracking at levels comparable to BM-based MRD testi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 93052206-06ce-5de9-9cdf-966208a56e6e
DOI: 10.1101/2025.10.24.25338566

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Cell-free DNA Whole Genome Sequencing for Non-Invasive Minimal Residual Disease Detection in Multiple MyelomaDOI 10.1101/2025.10.24.25338566Read

MinimuMM-seq: Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma PathologySemantic proximity Read

Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma.Semantic proximity Read

Monitoring minimal residual disease in the bone marrow using next generation sequencing.Semantic proximity Read

Circulating Tumour DNA for Detecting Minimal Residual Disease in Multiple MyelomaSemantic proximity Read

Deciphering response dynamics and treatment resistance from circulating tumor DNA after CAR T-cells in multiple myelomaSemantic proximity Read

Minimal residual disease in multiple myeloma: defining the role of next generation sequencing and flow cytometry in routine diagnostic useSemantic proximity Read

The Evolving Role of Genomic Technologies in Multiple Myeloma: Implications for Diagnosis, Risk Stratification and Resistance.Semantic proximity Read

Single-cell sequencing reveals the mechanisms of multiple myeloma progression: clarity or confusion?Semantic proximity Read

Noninvasive Molecular Monitoring in Multiple Myeloma Patients Using Cell-Free Tumor DNASemantic proximity Read

Monitoring multiple myeloma in the peripheral blood based on cell-free DNA and circulating plasma cellsSemantic proximity Read

Circulating Tumour DNA Analysis for Tumour Genome Characterisation and Monitoring Disease Burden in Extramedullary Multiple Myeloma.Semantic proximity Read

Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma.Semantic proximity Read